Pak1 plays a pathogenic role in cancer, infectious diseases (AIDS, malaria and flu), inflammatory diseases (asthma and arthritis), insulin-resistant diabetes (type 2), hypertension, obesity, and other diseases, and thus, several synthetic drugs that selectively block Pak1 have been developed. This evidence concerns the gene PAK1 and influenza.